New Generation of sGC Stimulators: Discovery of Imidazo[1,2-a]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension

Author:

Vakalopoulos Alexandros1ORCID,Wunder Frank1,Hartung Ingo V.1ORCID,Redlich Gorden1,Jautelat Rolf1,Buchgraber Philipp1,Hassfeld Jorma1,Gromov Alexey V.1,Lindner Niels1,Bierer Donald1,Gries Jörg1,Kroh Walter1,Paulsen Holger1,Mittendorf Joachim1,Lang Dieter1ORCID,Becker-Pelster Eva1,Brockschnieder Damian1,Geiss Volker1,Li Volkhart1,Straub Alexander1,Knorr Andreas1,Mondritzki Thomas12,Trübel Hubert12,Raschke Marian1,Schaefer Martina13,Thomas Dirk1,Sandner Peter14,Stasch Johannes-Peter15,Follmann Markus1ORCID

Affiliation:

1. Pharmaceuticals, Research and Development, Bayer AG, Aprather Weg 18a, 42113 Wuppertal, Germany

2. University of Witten/Herdecke, 58455 Witten, Germany

3. Lead Discovery, Nuvisan ICB GmbH, Muellerstrasse 178, 13353 Berlin, Germany

4. Department of Pharmacology, Hannover Medical School, 30625 Hannover, Germany

5. Institute of Pharmacy, Martin Luther University, 06120 Halle, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3